This site is intended for health professionals only

Transplantation

Stem cell treatment makes its move
Stem cell treatment makes its move
Stem cells, infection and future directions on the agenda
Stem cells, infection and future directions on the agenda
Phase III maribavir study begins
Phase III maribavir study begins
Study supports bortezomib for multiple myeloma treatment
Study supports bortezomib for multiple myeloma treatment
German company develops alternative to stem cell therapy
German company develops alternative to stem cell therapy
Developments in candidiasis treatment
Developments in candidiasis treatment
Forerunners in the field of HSCT, the EBMT gives us a window on its work
Forerunners in the field of HSCT, the EBMT gives us a window on its work
T-cell therapy hope in transplant cases
T-cell therapy hope in transplant cases
Study finds aciclovir benefit
Study finds aciclovir benefit
New therapies for cardiac transplantation
New therapies for cardiac transplantation
The organ transplantation debate in the EU
The organ transplantation debate in the EU
New immunosuppressive strategies
New immunosuppressive strategies
1 2 3 4





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x